Nice to see Bioshares back they have always had a bit of a soft spot for Phylogica, their ratings dropped from Class A to B but I assume that is largely just as a result of having the past partners walk - more partners &/or advancing a deal to a later stage and obviously that will lift back up.
Interesting to see the efficiency hurdle covered - that was always a suspect on assumption as to why some of those earlier partnerships didn't progress but was never mentioned as such - nice to see a bit of clarity there.
Nice to see Bioshares back they have always had a bit of a soft...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.010(0.77%) |
Mkt cap ! $761.1M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.32 | $1.29 | $744.7K | 570.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2108 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 27335 | 2 |
View Market Depth
| Last trade - 13.51pm 03/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |